Opioid Antagonism in Hypogonadotropic Hypogonadism
Status:
Recruiting
Trial end date:
2025-02-28
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the effects of opioid antagonists on the
hypothalamic-pituitary-gonadal axis in subjects with idiopathic hypogonadotropic hypogonadism
(HH).